These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32015441)

  • 1. A novel selection strategy for antibody producing hybridoma cells based on a new transgenic fusion cell line.
    Listek M; Hönow A; Gossen M; Hanack K
    Sci Rep; 2020 Feb; 10(1):1664. PubMed ID: 32015441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybridoma Technology.
    Hnasko RM; Stanker LH
    Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Antibody Discovery Based on Precise Selection of Single Transgenic Hybridomas with an On-Cell-Surface and Antigen-Specific Anchor.
    Li Y; Li P; Ke Y; Yu X; Yu W; Wen K; Shen J; Wang Z
    ACS Appl Mater Interfaces; 2022 Apr; 14(15):17128-17141. PubMed ID: 35385643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
    Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
    J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of mouse hybridomas by fusion of myeloma cells with lymphocytes derived from spleen, lymph node, and bone marrow.
    Başalp A; Yücel F
    Hybrid Hybridomics; 2003 Oct; 22(5):329-31. PubMed ID: 14678651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybridoma technologies for antibody production.
    Tomita M; Tsumoto K
    Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obtaining and characterization of monoclonal antibodies against recombinant extracellular domain of human epidermal growth factor receptor 2.
    Sarina N; Abeldenov S; Turgimbayeva A; Zhylkibayev A; Ramankulov Y; Khassenov B; Eskendirova S
    Hum Antibodies; 2018 Feb; 26(2):103-111. PubMed ID: 29036807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Murine Monoclonal Antibodies by Hybridoma Technology.
    Holzlöhner P; Hanack K
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new approach to the design of hybrid hybridomas based on the use of an actinomycin D-resistant line of murine myeloma].
    Massino IuS; Kizim EA; Dmitriev AD
    Biull Eksp Biol Med; 1991 Nov; 112(11):511-4. PubMed ID: 1687361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of antigen-specific antibody-secreting cells.
    Kishi H; Jin A; Ozawa T; Tajiri K; Obata T; Muraguchi A
    Methods Mol Biol; 2012; 853():141-50. PubMed ID: 22323145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-epitope masking: a strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surface.
    Shen R; Su ZZ; Olsson CA; Goldstein NI; Fisher PB
    J Natl Cancer Inst; 1994 Jan; 86(2):91-8. PubMed ID: 7505832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a strategy for the rapid generation of a monoclonal antibody against the human protein SNEV (hNMP200) by flow-cytometric cell sorting.
    Böhm E; Grillari J; Voglauer R; Gross S; Ernst W; Ferko B; Kunert R; Katinger H; Borth N
    J Immunol Methods; 2005 Dec; 307(1-2):13-23. PubMed ID: 16289093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and characterization of a mouse/human chimeric antibody specific for EGF receptor.
    Ferrer C; Anastasi AM; Di Massimo AM; Bullo A; Di Loreto M; Raucci G; Pacilli A; Rotondaro L; Mauro S; Mele A; De Santis R
    J Biotechnol; 1996 Nov; 52(1):51-60. PubMed ID: 9025323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitated cell fusion for hybridoma production.
    Conrad MK; Lo MM
    Methods Enzymol; 1990; 184():641-53. PubMed ID: 2167431
    [No Abstract]   [Full Text] [Related]  

  • 15. Production of Antibodies to Peptide Targets Using Hybridoma Technology.
    Trier NH; Friis T
    Methods Mol Biol; 2024; 2821():135-156. PubMed ID: 38997486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of monoclonal antibodies.
    Yokoyama WM; Christensen M; Santos GD; Miller D
    Curr Protoc Immunol; 2006 Sep; Chapter 2():2.5.1-2.5.25. PubMed ID: 18432969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry-based method for rapid and high-throughput screening of hybridoma cells secreting monoclonal antibody.
    Akagi S; Nakajima C; Tanaka Y; Kurihara Y
    J Biosci Bioeng; 2018 Apr; 125(4):464-469. PubMed ID: 29174537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of the hybridoma principle in 1968-69 immortalization of the specific antibody-producing cell by fusion with a lymphoma cell.
    Sinkovics JG
    J Med; 1985; 16(5-6):509-24. PubMed ID: 3868685
    [No Abstract]   [Full Text] [Related]  

  • 19. Increase of hybridoma formation by human lymphocytes after stimulation in vitro; effect of antigen, endothelial cells, and PWM.
    Astaldi GC; Wright EP; Willems C; Zeijlemaker WP; Janssen MC
    J Immunol; 1982 Jun; 128(6):2539-42. PubMed ID: 6804563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.
    Harris JF; Hawley RG; Hawley TS; Crawford-Sharpe GC
    J Immunol Methods; 1992 Apr; 148(1-2):199-207. PubMed ID: 1373425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.